Jim Simons Lexaria Bioscience Corp. Transaction History

Renaissance Technologies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.99 - $4.0 $45,372 - $91,200	22,800 New	22,800 $63,000
Q3 2023 Nov 14, 2023	BUY	$0.72 - $1.11 $1,584 - $2,442	2,200 Added 20.56%	12,900 $13,000
Q2 2023 Aug 11, 2023	SELL	$0.69 - $2.69 $2,000 - $7,801	-2,900 Reduced 21.32%	10,700 $8,000
Q1 2023 May 12, 2023	BUY	$2.47 - $3.47 $5,187 - $7,287	2,100 Added 18.26%	13,600 $37,000
Q4 2022 Feb 13, 2023	SELL	$1.95 - $2.98 $780 - $1,192	-400 Reduced 3.36%	11,500 $28,000
Q3 2022 Nov 14, 2022	BUY	$0.74 - $3.28 $296 - $1,312	400 Added 3.48%	11,900 $29,000
Q2 2022 Aug 12, 2022	BUY	$1.88 - $4.06 $21,620 - $46,689	11,500 New	11,500 $34,000
Q3 2021 Nov 12, 2021	SELL	$5.39 - $8.44 $92,708 - $145,168	-17,200 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$4.61 - $7.02 $79,292 - $120,743	17,200 New	17,200 $120,000

1.06M

Ticker LEXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,951,000
Market Cap $13.7M
Description
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.